Osimertinib in Previously EGFR-TKI Treated Non-Small Cell Lung Cancer (NSCLC) Patients Without T790M Mutation: Real-world Evidence.
JOURNAL OF CLINICAL ONCOLOGY(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2020)